Sales of Takhzyro amounted to 44.1 billion Japanese yen in the 3rd quarter of 2022, an increase of 42.7% from the previous year. Takeda Pharmaceutical's revenue was $8,354 million in Q3 2022, showing ...
In today’s ever-changing market place, pharmaceutical companies are challenged to reach, engage and persuade physicians in new, more effective ways. With changing behavioral influences, rising ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback